CCL2 and prostate cancer: As similarly observed in breast and prostate cancers and in a spontaneous model of lung metastasis, (48, 51, 57), alteration in the macrophage phenotype and activation of CD8+ T cells was obtained following MCP-1 neutralization (using monoclonal antibody or bindarit).